Personalis, Inc. (NAS: PSNL) Stock Analysis & Fundamentals | ScreenerHero

Create free account

PSNLPersonalis, Inc.

NAS · US · Healthcare · Diagnostics & Research · personalis.com

15.58USD-1.33%Mkt Cap: 1.63B $P/E: —1d ago

Personalis, Inc. develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally. The company offers NeXT Personal, a tumor-informed liquid biopsy test for detection of mi…

Industry Peers

Diagnostics & Research

Thermo Fisher Scientific Inc.

$201.86BUSDP/E 29.8

Danaher Corporation

$145.10BUSDP/E 39.7

$45.85BUSDP/E 44.2

IDEXX Laboratories, Inc.

$45.44BUSDP/E 42.4

Agilent Technologies, Inc.

$38.44BUSDP/E 27.3

Waters Corporation

$37.13BUSDP/E 48.1

IQVIA Holdings Inc.

$35.13BUSDP/E 26.2

$28.78BUSDP/E 34.6

Mettler-Toledo International Inc.

$26.98BUSDP/E 31.4

Quest Diagnostics Incorporated

$23.18BUSDP/E 23.1

Labcorp Holdings Inc.

$23.12BUSDP/E 25.0

Guardant Health, Inc.

Medpace Holdings, Inc.

$15.36BUSDP/E 33.9

Eurofins Scientific SE

$13.06BUSDP/E 27.3

$12.46BUSDP/E 53.7

Charles River Laboratories International, Inc.

bioMérieux S.A.

$9.26BUSDP/E 21.6

BillionToOne, Inc.

$5.90BUSDP/E 237.4

Twist Bioscience Corporation

Sotera Health Company

$5.21BUSDP/E 44.6

$4.73BUSDP/E 54.8

DiaSorin S.p.A.

$3.75BUSDP/E 26.5

Adaptive Biotechnologies Corporation

NeoGenomics, Inc.

GeneDx Holdings Corp.

Vimian Group AB (publ)

$1.64BUSDP/E 41.7

Diagnostyka S.A.

$1.48BUSDP/E 22.4

Clínica Baviera, S.A.

$1.02BUSDP/E 21.4

OPKO Health, Inc.

Castle Biosciences, Inc.

$616.40MUSDP/E 40.2

Myriad Genetics, Inc.

Fulgent Genetics, Inc.

$293.12MUSDP/E 2.9

Spectral Medical Inc.

Insight Molecular Diagnostics Inc.

Scope Fluidics S.A.

Eurofins-Cerep SA

$89.37MUSDP/E 17.2

Pangaea Oncology, S.A.

Abingdon Health Plc

Immunovia AB (publ)

Proteome Sciences plc

ENDRA Life Sciences Inc.

Oxford BioDynamics Plc

Avricore Health Inc.

bioAffinity Technologies, Inc.

Leveljump Healthcare Corp.

Prostatype Genomics AB (publ)

Telo Genomics Corp.

ProPhase Labs, Inc.

Many Bright Ideas Technologies Inc.

$314.2KUSDP/E Infinity

T2 Biosystems, Inc.

Indicators:|

Key Statistics

Company

Market Cap1.63B $

Enterprise Value1.46B $

Revenue (TTM)64.52M $

Gross Profit15.78M $

Net Income (TTM)-81.27M $

Revenue/Share0.6910 USD

Last Price15.58 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees259

CountryUS

SectorHealthcare

IndustryDiagnostics & Research

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-17.17

PEG—

EV/EBITDA-15.74

EV/Revenue22.62

P/S25.29

P/B6.40

EPS (TTM)-1.02

EPS (Forward)-0.91

52W Range

3.84095% of range16.15

52W High16.15 USD

52W Low3.840 USD

Profitability

Gross Margin22.65%

Oper. Margin-207.87%

EBITDA Margin-143.68%

Profit Margin-116.69%

ROE-31.12%

ROA-24.32%

Growth

Revenue Growth-24.90%

Earnings Growth—

Cash Flow & Leverage

Operating CF-74.95M $

CapEx (TTM)4.50M $

FCF Margin-65.65%

FCF Yield-2.60%

Net Debt-194.44M $

Net Debt/EBITDA2.10

Balance Sheet

Debt/Equity0.15

Current Ratio6.61

Quick Ratio6.31

Book Value/Sh2.433 USD

Cash/Share2.227 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating1.4 (Strong Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)12.57 USD

Upside (mean)-19.3%

Target Range10.00 USD – 18.00 USD

$10.00-19.3% to mean$18.00

# Analysts7

Ownership

Shares Out.104.72M

Float64.49M

Insiders26.67%

Institutions68.21%

Short Interest

Short Ratio3.1d

Short % Float17.05%

Short % Out.10.80%

Shares Short11.31M

Short (prev mo.)12.83M

Technical

SMA 5010.26 (+51.9%)

SMA 2008.713 (+78.8%)

Beta2.24

S&P 52W Chg20.25%

Avg Vol (30d)4.18M

Avg Vol (10d)4.87M

Technical Indicators

RSI (14)72.5

MACD1.5040

MACD Signal1.3707

MACD Hist.+0.1334

BB Upper17.07 USD

BB Middle13.01 USD

BB Lower8.955 USD

BB Width62.35%

ATR (14)1.171 USD

Vol Ratio (20d)2.97x